Changes in quality of life after hormonal treatment of endometriosis.

Bergqvist A, Theorell T

Acta obstetricia et gynecologica Scandinavica1 Jul 2001Cited by 55 (Europe PMC)

PMID11437721DOI10.1080/j.1600-0412.2001.800708.xPepBankPUB-11437721

Publisher page PubMedAsk about this study

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. 5 results from people.

01HumanRandomized controlled trialEfficacy outcome
In women with endometriosis, symptom scores did not differ significantly between nafarelin and medroxyprogesterone acetate.
In plain wordsSymptom scores were similar with nafarelin and medroxyprogesterone acetate in women with endometriosis.
Peptide
Nafarelin
Outcome
No significant changeSymptom score
Study
n: not reported in source
Comparator
Medroxyprogesterone acetate
Outcome group
Pain · Reproductive and sexual health
Studied dose
Dose not stated
Source sentences
Summary
There was a significant reduction in symptom score during the study, without any significant difference between the treatment groups.
1 context sentence(design, population, supporting numbers)
Summary · context
In a prospective, randomized, double-blind, double-dummy study on 48 women with verified endometriosis, the pain pattern and quality of life were registered before, during and after treatment with nafarelin or medroxyprogesterone acetate.
Report a problemFND-1143772101
02HumanRandomized controlled trialEfficacy outcome
In women with endometriosis, other psychosocial parameters did not differ between nafarelin and medroxyprogesterone acetate.
In plain wordsOther psychosocial measures were similar with nafarelin and medroxyprogesterone acetate.
Peptide
Nafarelin
Outcome
No significant changeOther psychosocial parameters
Study
n: not reported in source
Comparator
Medroxyprogesterone acetate
Outcome group
Quality of life · Mental health and mood
Studied dose
Dose not stated
Source sentences
Summary
All the other psycho-social parameters as well as emotional balance improved during the study period without difference between groups.
1 context sentence(design, population, supporting numbers)
Summary · context
In a prospective, randomized, double-blind, double-dummy study on 48 women with verified endometriosis, the pain pattern and quality of life were registered before, during and after treatment with nafarelin or medroxyprogesterone acetate.
Report a problemFND-1143772104
03HumanRandomized controlled trialEfficacy outcome
In women with endometriosis, emotional balance did not differ between nafarelin and medroxyprogesterone acetate.
In plain wordsEmotional balance was similar with nafarelin and medroxyprogesterone acetate.
Peptide
Nafarelin
Outcome
No significant changeEmotional balance
Study
n: not reported in source
Comparator
Medroxyprogesterone acetate
Outcome group
Quality of life · Mental health and mood
Studied dose
Dose not stated
Source sentences
Summary
All the other psycho-social parameters as well as emotional balance improved during the study period without difference between groups.
1 context sentence(design, population, supporting numbers)
Summary · context
In a prospective, randomized, double-blind, double-dummy study on 48 women with verified endometriosis, the pain pattern and quality of life were registered before, during and after treatment with nafarelin or medroxyprogesterone acetate.
Report a problemFND-1143772105
04HumanNon-randomized trialSafety outcome
In women with endometriosis, anxiety-depression scores increased during nafarelin treatment.
In plain wordsAnxiety-depression scores increased during nafarelin treatment in women with endometriosis.
Peptide
Nafarelin
Outcome
IncreaseAnxiety-depression during treatment
Study
n: not reported in source
Outcome group
Anxiety and mood · Mental health and mood
Studied dose
Dose not stated
Source sentences
Summary
but the anxiety-depression score increased during the nafarelin treatment period.
1 context sentence(design, population, supporting numbers)
Summary · context
In a prospective, randomized, double-blind, double-dummy study on 48 women with verified endometriosis, the pain pattern and quality of life were registered before, during and after treatment with nafarelin or medroxyprogesterone acetate.
Report a problemFND-1143772102
05HumanNon-randomized trialEfficacy outcome
In women with endometriosis, paid working life improved significantly in the nafarelin-treated group.
In plain wordsPaid working life improved during the study in women receiving nafarelin for endometriosis.
Peptide
Nafarelin
Outcome
Direction not reportedPaid working life
Study
n: not reported in source
Outcome group
Quality of life · Whole body
Studied dose
Dose not stated
Source sentences
Summary
There was a statistically significant improvement of paid working life in the nafarelin treated group.
1 context sentence(design, population, supporting numbers)
Summary · context
In a prospective, randomized, double-blind, double-dummy study on 48 women with verified endometriosis, the pain pattern and quality of life were registered before, during and after treatment with nafarelin or medroxyprogesterone acetate.
Report a problemFND-1143772103

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
28 Oct 2026, 02:03 UTC
Study results updated
Version 1
27 Oct 2026, 16:36 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.